CoChat

Transitioning Safely from Intravenous to Subcutaneous Insulin

Kreider, Kathryn Evans, Lien, Lillian F. · 2015 · Current Diabetes Reports

The DOI matches its Crossref record; the references it cites are not checked yet.

Abstract

The transition from intravenous (IV) to subcutaneous (SQ) insulin in the hospitalized patient with diabetes or hyperglycemia is a key step in patient care. This review article suggests a stepwise approach to the transition in order to promote safety and euglycemia. Important components of the transition include evaluating the patient and clinical situation for appropriateness, recognizing factors that influence a safe transition, calculation of proper SQ insulin doses, and deciding the appropriate type of SQ insulin. This article addresses other clinical situations including the management of patients previously on insulin pumps and recommendations for patients requiring glucocorticoids and enteral tube feedings. The use of institutional and computerized protocols is discussed. Further research is needed regarding the transition management of subgroups of patients such as those with type 1 diabetes and end-stage renal disease.

Overview

Integrity signals

Registry

Crossref · 10.1007/s11892-015-0595-4

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

The citation lists are queued

They are fetched later and appear here then.

References 70 · Cited by 36

Research works printed but not linked: 2

  1. Hemerson P, Banarova A, Izakovic M, et al. Transitioning postoperative cardiovascular surgery patients from intravenous to subcutaneous insulin: an improvement project. J Clin Outcomes Manag JCOM. 2011;18(12):563–7.
  2. Palazzo A, Smith B, Shoun F, et al. Use of the eGlycemic management system by glytec provides safe and effective transition from iv to subq insulin therapy. Diabetes technology meeting; November 6–8. Diabetes Technology Society: Bethesda; 2014.

Metadata

Authors
Kreider, K. E., & Lien, L. F.
Affiliations
  • Duke University (US)
  • University of Mississippi Medical Center (US)
Corresponding author
Kreider, Kathryn Evans
Venue
Current Diabetes Reports
Published
2015-03-15
Volume
15
Issue
5
Pages
23-23
ISSN
  • 1534-4827 (ISSN-L)
  • 1539-0829
OpenAlex
W1982545756
Cited by
36
References
70
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 3 · 2019: 1 · 2018: 2 · 2017: 6 · 2016: 3 · 2015: 1
FWCI
0.60
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Current Diabetes Reports (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
hospitalized patients, diabetes mellitus, hyperglycemia, glucocorticoids, enteral nutrition, normoglycemia, type 1 diabetes, end-stage renal disease
MeSH terms
Clinical Decision-Making, Dose-Response Relationship, Drug, Humans, Injections, Subcutaneous, Insulin, Blood Glucose Self-Monitoring, Administration, Intravenous

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Transitioning Safely from Intravenous to Subcutaneous Insulin. https://app.cochat.ai/papers/10.1007/s11892-015-0595-4
The paper
Kreider, K. E., & Lien, L. F. (2015). Transitioning Safely from Intravenous to Subcutaneous Insulin. Current Diabetes Reports. https://doi.org/10.1007/s11892-015-0595-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.